Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 0.24%.

  • Harmony Biosciences Holdings' Return on Capital Employed changed 0.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.26% for FY2024, which is 700.0% down from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Return on Capital Employed is 0.24%, which was down 0.0% from 0.25% recorded in Q2 2025.
  • Harmony Biosciences Holdings' Return on Capital Employed's 5-year high stood at 0.3% during Q4 2023, with a 5-year trough of 0.11% in Q1 2021.
  • For the 5-year period, Harmony Biosciences Holdings' Return on Capital Employed averaged around 0.24%, with its median value being 0.24% (2025).
  • Per our database at Business Quant, Harmony Biosciences Holdings' Return on Capital Employed surged by 1800bps in 2021 and then tumbled by -700bps in 2025.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Return on Capital Employed stood at 0.24% in 2021, then fell by -15bps to 0.21% in 2022, then soared by 47bps to 0.3% in 2023, then dropped by -21bps to 0.24% in 2024, then dropped by 0bps to 0.24% in 2025.
  • Its Return on Capital Employed was 0.24% in Q3 2025, compared to 0.25% in Q2 2025 and 0.23% in Q1 2025.